As recomendações recentemente reafirmadas pela Organização Mundial da Saúde (OMS) sobre a importância da embalagem (rótulos) clara de medicamentos antimicrobianos encontram respaldo em evidências científicas produzidas pelo projecto ABACUS (AntiBiotic ACcess and Use), implementado em vários países, incluindo Moçambique.

A new research project implemented by CISM, with funding from the Calouste Gulbenkian Foundation, aims to strengthen infectious disease surveillance in Mozambique through the analysis of wastewater and the application of the integrated One Health approach, which links human, animal, and environmental health.

Two researchers from the Manhiça Health Research Centre (CISM) recently participated in a specialized training on antimicrobial resistance (AMR), held in Johannesburg, South Africa. The course took place from March 8 to 13, 2026, and was organized by Wellcome Connecting Science in collaboration with the National Institute for Communicable Diseases (NICD), bringing together scientists, microbiologists, clinicians, epidemiologists, and bioinformaticians from several African cou

The Manhiça Health Research Centre (CISM) will implement a new study aimed at assessing the acceptability and feasibility of an innovative strategy for malaria prevention, based on long-acting injections. The research, entitled “Acceptability and Operational Feasibility of Long-Acting Malaria Prophylaxis in Endemic Districts of Mozambique”, emerges in response to persistent challenges in controlling the disease, which remains one of the leading causes of mortality in the coun

Picture: CISM archive An article published under the CHAMPS network (Child Health and Mortality Prevention Surveillance) reveals that HIV remains one of the leading causes associated with mortality among children under five years of age in high-prevalence countries, including Mozambique, Kenya, Sierra Leone, and South Africa. The CHAMPS network, which implements post-mortem surveillance systems across eight countries, has operated in Mozambique since 2016, in the districts o

The initiative is being implemented within the framework of the POCUS-4TB project. The Manhiça Health Research Centre (CISM), in collaboration with the London School of Hygiene & Tropical Medicine (LSHTM) , will implement a pioneering project aimed at evaluating the potential of chest ultrasonography (ultrasound) as a tool to support the diagnosis of tuberculosis (TB) in children. The initiative, entitled “Point-of-care ultrasound for tuberculosis diagnosis: preliminary phase

Participants at the meeting in Maputo The Manhiça Health Research Centre (CISM) hosted, from 5 to 7 November 2025, the second in-person meeting of the Crypto T&T (Cryptosporidiosis Test & Treat) project. The initiative aims to assess the effectiveness of a low-cost point-of-care test, followed by targeted treatment for cryptosporidiosis with nitazoxanide (an antiparasitic medicine), in reducing the duration of diarrhoea among children presenting with diarrhoea at health faci

Photo: AHRI Original text published on the University of Bergen (UiB) website A crucial discussion recently took place among stakeholders regarding a new rapid testing and treatment strategy aimed at combating Cryptosporidiosis Diarrhea (CryptoT&T) in children. The initiative seeks to curb the spread of the disease and mitigate its harmful effects on child lives. Cryptosporidiosis is an intestinal infection caused triggered by the Cryptosporidium parasite. It predominantly af